arrow
BackJournal Details
npj Breast Cancer cover

npj Breast Cancer

IF7.6
Papers1046
Citations4193
Journal Papers 1031
Publication Date
Artificial intelligence for clinical data extraction from EHRs in breast cancer trials: the MIRROR study
delete2026-10-07
delete0
deleteOAAI
deleteCarlos Luis Parra-Calderón; Leonardo Mina; Manuel Ruiz-Borrego; Joan García; Carlos Daniel Domínguez; Joan Guich; Marta Martínez de Falcón; Cristina Fernández; Sara González-García; Carlos Jiménez-Cortegana; Daniel Alcalá-López; Miguel Sampayo-Cordero; José Manuel Pérez-García; Antonio Llombart-Cussac; Alicia García-Sanz; Javier Cortés; María Campos
deleteShare
deleteSave
Key considerations for window of opportunity trials and preoperative endocrine therapy in breast cancer
delete2026-10-06
delete0
deleteOAAI
deleteLucy Haggstrom; Rebecca Burrell; Andrew Parker; Kate Middleton; Sarah Childs; Alan S. Coates; Elgene Lim; Richard D. Baird
deleteShare
deleteSave
Understanding mechanisms of PARP inhibitor resistance
delete2026-09-30
delete0
deleteOAAI
deleteJosep V. Forment; Mark J. O’Connor
deleteShare
deleteSave
Next-generation PARP1-selective inhibition and combination therapy in breast cancer
delete2026-09-30
delete0
deleteOAAI
deleteTejaswini P. Reddy; Bora Lim; Timothy A. Yap
deleteShare
deleteSave
Obesity impairs the antitumor activity of CAR-T cells in triple-negative breast cancer
delete2026-09-29
delete0
deleteOAAI
deleteHannah M. Malian; Caroline Marnata Pellegry; Hannah M. Oh; Elaine M. Glenny; Alyssa N. Ho; Gianpietro Dotti; Stephen D. Hursting; Michael F. Coleman
deleteShare
deleteSave
Left-right asymmetry in the breast TME is associated with distinct bioelectric and epigenetic tumor features
delete2026-09-26
delete0
deleteOAAI
deleteSebastián Real; Sergio Laurito; Nadia Bannoud; Pablo González; Oscar Bello; Diego Croci; João Carvalho; María Roqué
deleteShare
deleteSave
TRIM21-mediated OGT degradation inhibits breast cancer tumorigenesis and metastasis
delete2026-09-24
delete0
deleteOAAI
deleteAo Zhang; Fei Tang; Jiawen Zhou; Qi Wang; Miao Zhao; Jiuling Zhu; Ziyang Yuan; Zhe Sun; Miaolei Chen; Qianqian Shi; Lei Wu; Guodong Chen; Yuxin Shu; Xintian Chen; Shu Li; Zhongwei Li
deleteShare
deleteSave
Validation of a multi-omic biosignature for locoregional recurrence and radiation therapy benefit in breast cancer
delete2026-09-24
delete0
deleteOAAI
deleteGregory Bruce Mann; Karuna Mittal; Richard De Boer; Caroline MacCallum; Michael Alvarado; Michael Christie; Yiwei V. Zou; Frank Vicini; Chirag Shah; Meghan Kruse; Hope S. Rugo; Mark Mentrikoski; Jess Savala; David Dabbs; Steven C. Shivers; Pat Whitworth; Troy Bremer
deleteShare
deleteSave
Progesterone reshapes the tumor immune microenvironment toward macrophage-driven immune suppression in hormone receptor–positive breast cancer
delete2026-09-15
delete0
deleteOAAI
deleteEilidh I. Chowanec; Halyna Fedosyuk; Julio C. Tinoco; Amanda Heard; Harmony I. Saunders; Prabhakar Chalise; Zachary C. Hartman; Mary A. Markiewicz; Jeffery Vahrenkamp; Jason Gertz; Christy R. Hagan
deleteShare
deleteSave
Genomic biomarkers of ipatasertib response in patients with hormone receptor-positive metastatic breast cancer
delete2026-09-14
delete0
deleteOAAI
deleteMaxwell R. Lloyd; Zahra Bagheri; Elizabeth C. Scott; Geoffrey G. Fell; Lianne Ryan; Jennifer C. Keenan; Andrzej Niemierko; Laura M. Spring; Jennifer Shin; Steven J. Isakoff; Beverly Moy; Sarah Padden; Elizabeth Fisher; Amber Newton; Karleen R. Habin; Elene T. Viscosi-Spieler; Lauren Scarpetti; Andreas Varkaris; Leif W. Ellisen; Taronish Dubash; Dante Che; Parasvi S. Patel; Ferran Fece de la Cruz; Douglas S. Micalizzi; Shyamala Maheswaran; Daniel A. Haber; Dejan Juric; Aditya Bardia; Seth A. Wander
deleteShare
deleteSave
Assessing the prognostic utility of Oncotype Dx among patients with ER-low-positive breast cancer in the National Cancer Database (NCDB)
delete2026-09-11
delete0
deleteOAAI
deleteMadelyn F. Klugman; Ruizhe Chen; Maya Aboumrad; Catherine H. Marshall; Antonio C. Wolff; Jenna V. Canzoniero; Kala Visvanathan
deleteShare
deleteSave
Spatial structures of tumor and immune cells shape outcomes in ER⁺HER2⁻ and triple-negative breast cancer
delete2026-09-08
delete0
deleteOAAI
deleteIris Nederlof; Siamak Hajizadeh; Rolf Harkes; Barbara Andrade Barbosa; Michiel de Maaker; Ingrid Hofland; Dennis Peters; Robert Elens; Annegien Broeks; Erik van Werkhoven; Yongsoo Kim; Marieke Ijsselstein; Noel F. C. C. de Miranda; Sophie Bosma; Nicole C. M. Visser; Malou L. H. Snijders; Joyce Sanders; Roberto Salgado; Philip Poortmans; Astrid Scholten; Liesbeth J. Boersma; Marleen Kok; Harry Bartelink; Marc J. Van De Vijver; Hugo M. Horlings
deleteShare
deleteSave
Benmelstobart plus antiangiogenic therapy vs chemotherapy for metastatic triple-negative breast cancer: phase III trial
delete2026-09-04
delete0
deleteOAAI
deleteJiayu Wang; Quchang Oyang; Zhihong Wang; Qingyuan Zhang; Yu Ren; Jincai Zhong; Tao Sun; Zhongsheng Tong; Wenxian Zhou; Xiaojia Wang; Yahua Zhong; Xiaohua Zeng; Yuee Teng; Jing Sun; Yunhong Xia; Cuizhi Geng; Fuming Qiu; Lu Gan; Huadong Zhao; Ning Liao; Hongyan Ying; Xiaoyan Li; Xunqiang Wang; Binghe Xu
deleteShare
deleteSave
A meta-analysis of single agent and dual immune checkpoint inhibitors in metastatic triple negative breast cancer
delete2026-09-01
delete0
deleteOAAI
deletePhaedon D. Zavras; Hugo R. Lara-Martinez; Qi Nie; Ming Li; Zehui He; Julius Y. Kattoula; Nicole Strossman; Roisin M. Connolly; Romualdo Barroso-Sousa; Isaac S. Chan; Sara M. Tolaney; Sylvia Adams; Vered Stearns; Cesar A. Santa-Maria; Evanthia T. Roussos Torres
deleteShare
deleteSave
AI-driven resolution of uncertain histopathology in cases initially misdiagnosed as triple-negative breast cancer
delete2026-08-31
delete0
deleteOAAI
deleteMark G. Evans; Jennifer R. Ribeiro; Anthony Helmstetter; Sachein Sharma; Casey Bales; Todd Maney; George W. Sledge; David Spetzler; Ari Vanderwalde; Mary Lou Smith; Matthew Oberley; Priyanka Sharma; Steven Smith; Arielle Heeke; Sandra Swain; Edi Brogi; Farah Abdulla; Dave Bryant; Stuart J. Schnitt; Hassan Ghani
deleteShare
deleteSave
Genomic characterization of ER-positive primary tumors and corresponding relapses identifies potentially targetable alterations
delete2026-08-30
delete0
deleteOAAI
deleteCaroline Schagerholm Stanev; Stephanie Robertson; Hosein Toosi; Emmanouil G. Sifakis; Jens Lagergren; Johan Hartman
deleteShare
deleteSave
Activation of FcγR and classical complement pathways contribute to T-DXd plus pertuzumab therapeutic efficacy
delete2026-08-29
delete0
deleteOAAI
deleteLi-Chung Tsao; John S. Wang; David T. Severson; Sirajbir Sodhi; Herbert Kim Lyerly; Zachary C. Hartman
deleteShare
deleteSave
AI-derived tumor-infiltrating lymphocytes enhance the prediction of pathologic complete response in early-stage triple-negative breast cancer
delete2026-08-29
delete0
deleteOAAI
deleteXiaoxi Pan; Caner Ercan; Zhongya Wang; Roland L. Bassett; Karina B. Pinao Gonzales; Gaiane M. Rauch; Beatriz E. Adrada; Rosalind P. Candelaria; Debu Tripathy; Jennifer K. Litton; Sharon H. Giordano; Vicente Valero; Banu Arun; Alyson Clayborn; Kiran Virani; Jason White; Qingqing Ding; Aysegul A. Sahin; William Fraser Symmans; Clinton Yam; Lei Huo; Yinyin Yuan
deleteShare
deleteSave